Open Access

New insights on CETP inhibitors from genetic research and clinical trials

Topic: Lipid-Lowering Agents
Sponsored by PACE-CME – Supported by an unrestricted educational grant from Menarini and NewAmsterdam Pharma

Congress Presentation

About the speaker

Professor John Kastelein

Faculty of Medecine - University of Amsterdam, Amsterdam (Netherlands (The))
34 presentations
6 followers

4 more presentations in this session

Introduction

Speaker: Professor E. Stroes (Amsterdam, NL)

Thumbnail

Unmet needs in lowering LDL-c: barriers to goal attainment and need for innovative targets

Speaker: Professor S. Nicholls (Melbourne, AU)

Thumbnail

Exploring the role of novel CETP inhibitors in lipid management

Speaker: Professor R. Mehran (New York, US)

Thumbnail

Discussion

Speaker: Professor E. Stroes (Amsterdam, NL) Professor S. Nicholls (Melbourne, AU) Professor J. Kastelein (Amsterdam, NL) Professor R. Mehran (New York, US)

Thumbnail

Access the full session

Role of CETP inhibitors in cardiovascular risk reduction: will lessons from the past lead to future success?

Speakers: Professor J. Kastelein, Professor E. Stroes, Professor S. Nicholls, Professor R. Mehran, Professor E. Stroes...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations